Skip to content
Reckitt Benckiser
Search
Join RB’s networks
Facebook
LinkedIn
Twitter
YouTube
Google Plus
Weibo
RB Early Life Blog
Share
Sitemap
HTML version
Text only version
RB worldwide
Global locations
Executive Committee
The Board
RB history
Vision and values
Contact us
Careers & students
Apply now
Why join us?
Jobs for professionals
Graduates & Interns
What it's like at RB
Brand Me
Just for fun
Innovators
Products
People
Awards
Our brands
Powerbrands on the shelf
Products around the home
Commercial break
Search RB Brands A-Z
Category performance
Healthcare Brands Employee Reporting
Suboxone, Subutex & Temgesic adverse events reporting
Our responsibility
betterbusiness
Our Home Our Planet
Trees for Change
Community
Healthier kids Happier homes
Policies & reports
Contact us
Investors & media
Announcements & presentations
The talk about RB
Investor information
Category performance
Corporate governance
Share price information
Shareholder information
Patient organisation donations
Joint working executive summaries
Newsletter registration
Financial support for Healthcare Professionals
Contact us
Home
>
Investors & media
>
Joint working executive summaries
Investors & media
Announcements & presentations
The talk about RB
Investor information
Category performance
Corporate governance
Share price information
Shareholder information
Patient organisation donations
Joint working executive summaries
Newsletter registration
Financial support for Healthcare Professionals
Contact us
Joint working executive summaries
Intervention and training in prevention of skin damage
The issue
Patients in care for extended periods are at risk from skin damage. Various factors e.g. nutrition, hydration, nursing procedures, medication, skin dryness, age, underlying skin disease, co-morbidity, patients weight and mattresses can all increase that risk. Development of pressure sores and skin tears are distressing to patients, require expensive and lengthy intervention to resolve and frequently result in extended hospital stays, patient disatisfaction and extended care on discharge. Reducing incidence of care setting acquired skin damage is a desirable outcome for patients and healthcare teams. By adherence to risk assessment and skin care procedures, many if not all of these injuries can be prevented.
The challenge
To reduce the incidence of care setting acquired skin damage. This would result in improved patient experience, reduced hospital residency time, more appropriate use of tissue viability nurses and reduced financial resource through a focus on risk assessments, training and healthcare intervention.
Key actions
Conduct baseline audit to assess risk assessment completion and adherence to reccomendations. Implement interventional procedures to address any issues from baseline audit including training. Carry out follow up audit at 6 and 12 months to assess if interventions and training have produced reduced incidence of skin damage.
The outcome
Patient benefits
Patient centred care
Using quality and outcomes to shape service
Focus on prevention
The provision of care pathway, providing a seamless care to those patients at risk of skin injury
Avoiding/reducing unnecessary extended stays in hospital.
With assessment, care plan and implementation at the care facility, patients will experience improved quality of care and outcomes.
Safeguarding the most vulnerable
Constant care
NHS partner benefits
Reduced incidence of grade 3 or 4 pressure ulcers and skin tears.
Reduced patient residency time in the facility.
Improved capacity for the healthcare staff.
Reduced costs in bed time, nursing time and dressings to treat the patients
Legacy training tools and care packages for the trust to ensure care standards are maintained.
Demonstration of Integrated care using TVNs, Nurses, Pharmacists, dieticians and clinicians
RB company benefits
Build effective working relationships with the Western HSC trust– to use as a case study
Build on reputation amongst WHSC Trust & industry
Audit may be used as evidence to replicate this service model across other areas.
Evidence of effective use of emollients and of non detergent soaps in skin care.
Current status
Active March 2013–March 2014
Contact: Edward Vining, Healthcare Development Manager
Business address: Reckitt Benckiser Healthcare (UK) ltd, Dansom Lane, Hull HU8 7DS
Email: edward.vining@rb.com
Code: UK/E45-NHS/0213/0004
Speech Language Therapy Reflux Management & Respiratory Audit
The issue
The Speech Language therapist is well placed to diagnose and treat symptoms of reflux commonly seen in both ENT & Respiratory patient referrals
The challenge
There is a need to provide evidence and data on the effectiveness of SLT intervention in terms of the QIPP principles to support an invest to save model.
Key actions
Strengthen service set up through project team.
Conduct audit on past, present, and future potential of service.
Using evidence from audit to engage stakeholders to support service
The outcome
Patient benefits
Audit of this SLT service will identify its true potential to provide an improved level of care to the patient.
The Audit will capture the benefits of SLT intervention to improve level of care & treatment of very common condition by showing impact on service and patient outcomes.
A clearer pathway of care so patient diagnosed and treated effectively
Patient empowered through better improved understanding on their conditions and treatment options
NHS partner benefits
The audit will identify the true potential the SLT service can offer the NHS
Project will aim to deliver on QIPP Principles
Produce quality outcomes with a better more effective service and level of care. (measured through reduction of repeat referrals, patient outcome survey & resolution of symptoms)
Innovation – clearer pathway of care identified - to save money and make service more effective
Productivity - Audit will show rate of unnecessary referrals and readmissions and identify potential cost savings through delivering effective SLT intervention.
Prevention - Reduced number of readmissions & inappropriate referrals. By understanding their condition, patients empowered to self manage and not left reliant on long term acid suppression.
RB company benefits
Build effective working relationships with NHS – to use as case study
Build on reputation amongst NHS & Industry.
Audit may be used as evidence to replicate this service model across other localities
Documented insight into reflux associated respiratory conditions
Current status
Active Jan 2011 – Jan 2012
Parallel Hoarse Voice clinic
The issue
The ENT Head and Neck Cancer Service currently provides a clinic in which all new patients with a suspicion of Throat Cancer are seen by medical staff. An average of between 40 and 50 patients a week are seen in the clinic and over a 100 patients are diagnosed with Throat Cancer annually in the North East of Scotland.
Not all patients with sore throats and voice changes attending turn out to have cancer, and the Head and Neck clinic is becoming overburdened with new referrals of anxious patients. This has a knock on effect on those patients attending the clinic with diagnosed cancer and less clinical time is available and delays are commonplace. Many of these new referrals could be seen elsewhere. Also urgent referrals for assessment of Hoarseness impact on the number of patients seen at the general ENT clinic with an average of 30 patients (2009) per month seen at this clinic.
The challenge
Redesign the ENT and Head and Neck Service to free up valuable time particularly for the cancer patients while still offering a rapid and reassuring service for those patients in whom there is nothing serious.
Key actions
The project team will ensure that the service supports the needs of the patient
Audit numbers of patients over a 6 month period where management outcomes and patient experiences will be recorded
Use evidence from audit to engage stakeholders to support service for longer term
The outcome
Patient benefits
The SALT (Speech and Language Therapy) led clinic will triage patients so that only those with cancer need to be seen at the Cancer clinic while those with benign pathology can be reassured and managed accordingly
Avoids unnecessary attendance at a cancer clinic, which can lead to worry and apprehension
Faster access to appropriate Healthcare personnel and less waiting times
NHS partner benefits
This joint working project should in the future lead to direct referrals to the Parallel Hoarse voice clinic, bypassing the need for consultant vetting of patients
Improved service efficiency and free up clinic appointments thus helping to achieve waiting time targets and increase in outpatient clinic capacity
Cost efficiencies through utilisation of appropriate professional skills and equipment aligned to strict protocol and process
This service will offer a rapid and reassuring service for those who have suspected cancer therefore ensuring all patients, with or without serious pathology, are treated appropriately and promptly
RB company benefits
Build effective working relationships with NHS – to use as case study
Build on reputation amongst NHS & Industry
Audit may be used as evidence to replicate this service model across other localities
Current status
Active October 2012 to October 2013
Print this page